<p>Experimental groups of mice used in the immunogenicity and protective potential trials of Protein A vaccines (n = 48).</p
<p>Female BALB/c mice received immunizations at three week intervals either sequentially or in combi...
<p>Serum bactericidal titres of sera (pools of four mice, five pools per group) were determined agai...
<p>Serum neutralizing (neut) antibody and lung virus titers for each vaccine dosage group. A. Geomet...
Groups of 10 Balb/c mice were immunized with Flg-HA2-2-4M2e, Flg-HA2-1-4M2e, or Flg-4M2e fusion prot...
<p>Immunogenicity of VLP-VP2 in mice (determination of antibody titers of VLP-VP2 in mice).</p
<p>Mice were divided over seven groups and were either vaccinated twice with subunit vaccine with or...
<p>Per antigen, eight mice were vaccinated twice with 5 µg antigen mixed with an oil-in-water adjuva...
(A) Vaccination schedule to evaluate immunogenicity in male AKR/J mice. Humoral immune response was ...
<p>Numbers of (<b>A</b>) E6-specific CD8<sup>+</sup> T precursors and (<b>B</b>) E7-specific CD8<sup...
<p>Different experimental groups were designed for the development of the pre-clinical trials of the...
Mice (n = 5) were immunised with a panel of GP encapsulated antigens and the development humoral and...
<p>Serum bactericidal titres of sera (pools of four mice, five pools per group) were determined agai...
(A) Vaccine schedule to measure efficacy and post-challenge anamnestic response in male AKR/J mice. ...
<p>Clinical signs observed in different groups of mice immunized with Protein A (Observations up to ...
<p>Experimental design showing the number of mice allocated to the Nor, SCI, LIF and Sham groups.</p
<p>Female BALB/c mice received immunizations at three week intervals either sequentially or in combi...
<p>Serum bactericidal titres of sera (pools of four mice, five pools per group) were determined agai...
<p>Serum neutralizing (neut) antibody and lung virus titers for each vaccine dosage group. A. Geomet...
Groups of 10 Balb/c mice were immunized with Flg-HA2-2-4M2e, Flg-HA2-1-4M2e, or Flg-4M2e fusion prot...
<p>Immunogenicity of VLP-VP2 in mice (determination of antibody titers of VLP-VP2 in mice).</p
<p>Mice were divided over seven groups and were either vaccinated twice with subunit vaccine with or...
<p>Per antigen, eight mice were vaccinated twice with 5 µg antigen mixed with an oil-in-water adjuva...
(A) Vaccination schedule to evaluate immunogenicity in male AKR/J mice. Humoral immune response was ...
<p>Numbers of (<b>A</b>) E6-specific CD8<sup>+</sup> T precursors and (<b>B</b>) E7-specific CD8<sup...
<p>Different experimental groups were designed for the development of the pre-clinical trials of the...
Mice (n = 5) were immunised with a panel of GP encapsulated antigens and the development humoral and...
<p>Serum bactericidal titres of sera (pools of four mice, five pools per group) were determined agai...
(A) Vaccine schedule to measure efficacy and post-challenge anamnestic response in male AKR/J mice. ...
<p>Clinical signs observed in different groups of mice immunized with Protein A (Observations up to ...
<p>Experimental design showing the number of mice allocated to the Nor, SCI, LIF and Sham groups.</p
<p>Female BALB/c mice received immunizations at three week intervals either sequentially or in combi...
<p>Serum bactericidal titres of sera (pools of four mice, five pools per group) were determined agai...
<p>Serum neutralizing (neut) antibody and lung virus titers for each vaccine dosage group. A. Geomet...